Quest Pap Smear for the Pancreas

What brought about this remarkable change was the widespread adoption in the 1960’s of screening cytology. In the routine cervical Pap smear, a sample of cells (cytology) is obtained by a gynecologist from the surface of the cervix. This cytology sample is then examined under the microscope at Quest Diagnostics and other laboratories for the presence of still-harmless but precancerous cells. Detecting and removing precancer can prevent cancer before it can start.

How it works

For the pancreatic cancer screening procedure, a minimally invasive endoscopy is performed by a gastroenterologist to obtain a sample of the fluid that is normally released by the pancreas after you have a meal. Prior to the endoscopy, an ultrasound probe is placed over your abdomen and 15 minutes of FDA-cleared, low-intensity, non-focused ultrasound (LINFU^®) is administered. This is designed to increase the number of cells that are naturally shed into the pancreatic fluid in order to enrich the cytologic specimen that will be analyzed by the laboratory. For additional information on the LINFU technology, please visit www.adenocyte.com.

A simple process